Results 131 to 140 of about 84,892 (241)

Human T-Lymphotropic Virus-1/2 Infection in Central Brazil Prisons: A Multicenter Study. [PDF]

Front Microbiol, 2021
Melo Bandeira L, Moreira Puga MA, Croda J, Pompílio MA, Amianti C, Rocha de Rezende G, Coimbra Motta-Castro AR.   +6 more
europepmc   +1 more source

Spread of Human T-Lymphotropic Virus 1 and 2 Among Relatives of People Who Use Illicit Drugs in Northern Brazil. [PDF]

Front Microbiol, 2022
Oliveira-Filho AB, Frade PCR, Fonseca RRS, Sawada L, Martins LC, Machado LFA, Vallinoto ACR, Ishak R, de Lemos JAR, Fischer B, Kupek E.   +10 more
europepmc   +1 more source

Occupational Therapy for People Living With Human T-Lymphotropic Virus 1: Importance and Effectiveness of an Intervention Plan at the Level of Prevention and Rehabilitation. [PDF]

Front Med (Lausanne), 2022
Sampaio EC, Aben-Athar CYUP, Pinto DDS, Vallinoto ACR, Cayres Vallinoto IMV.   +4 more
europepmc   +1 more source

Histopathological differences between human T-lymphotropic virus type 1-positive and human T-lymphotropic virus type 1-negative polymyositis [PDF]

Clinical and Experimental Neuroimmunology, 2011
Hazem M. Abdullah, Itsuro Higuchi, Ryuji Kubota, Eiji Matsuura, Akihiro Hashiguchi, Nashwa H. Abdelbary, Yukie Inamori, Hiroshi Takashima, Shuji Izumo   +8 more
openaire   +1 more source

Differential modulation of IL-4, IL-10, IL-17, and IFN-γ production mediated by IgG from Human T-lymphotropic virus-1 (HTLV-1) infected patients on healthy peripheral T (CD4+, CD8+, and γδ) and B cells. [PDF]

Front Med (Lausanne), 2023
Machado NR, Fagundes BO, Fernandes LA, de Oliveira ACP, Nukui Y, Casseb J, Cunha FRM, Nali LHDS, Sanabani SS, Victor JR.   +9 more
europepmc   +1 more source

Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review. [PDF]

Viruses, 2021
Stufano A, Jahantigh HR, Cagnazzo F, Centrone F, Loconsole D, Chironna M, Lovreglio P.   +6 more
europepmc   +1 more source

Seroprevalence Of Hepatitis-b Virus In Mid And Far Western Region In Nepal [PDF]

, 2012
Hepatitis B is significant health problems that might involve the late sequel of liver cirrhosis and hepatocellular carcinoma. The present study aimed to know the seroprevalence of hepatitis B virus (HBV) in mid and far western region in Nepal with ...
H, S. A. (Siddiqui), M, A. (Ansari), P, S. (Singh), S, K. (Khan)   +3 more
core  

بررسی همراهی ژنوم HTLV-1 با سرطان‌های مهبل و گردن رحم [PDF]

, 2009
زمينه و هدف: تاکنون چندين نوع ويروس، که مسبب ايجاد تقريباً 15% تمام تومورهای انسان هستند، شناخته شده‌اند. ويروس لوسمی لنفوم سلول T بالغين (HTLV-1)، يکی از رتروويروس‌های انسانی است که باعث لوسمی و لنفوم از نوع سلول T در بالغين و ميلوپاتی اسپاستيک تروپيکال
خويی, علیرضا, صداقت, مینو, فرزادنيا, مهدی, محمودی, محمود   +3 more
core  

In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection

Proceedings of the National Academy of Sciences of the United States of America, 2007
Becca Asquith, Yan Zhang, A. Mosley, C. D. de Lara, D. Wallace, A. Worth, Lambrini Kaftantzi, Kiran N Meekings, G. Griffin, Yuetsu Tanaka, D. Tough, P. Beverley, G. Taylor, D. Macallan, C. Bangham   +14 more
semanticscholar   +1 more source

How serious is the risk of HTLV-1 infection in Iranian hemodialysis-dependent patients?

BMC Nephrology
Objective The transmission of infectious agents through hemodialysis is one of this critical treatment’s most significant side effects. Human T-lymphotropic virus 1 (HTLV-1) is an endemic oncogenic virus in Iran.
Mahdi Mohammaditabar, Mohammad-Moien Forghani-Ramandi, Niusha Amirani, Sofia Saidi, Sama Zare, Negin Fathi Hafshejani, Sayed-Hamidreza Mozhgani   +6 more
doaj   +1 more source